For example, Erk1/2 activation was enhanced in human AAA lesions and Ang II-infused mouse aneurysmal aortic media [40] whereas compounds that attenuated Ang II-induced AAA were found to block Erk1/2 activation [41, 49, 50]. This evidence concerns the gene MAPK3 and triple-A syndrome.